Immune signature as a potential marker for predicting response to immunotherapy in obesity-associated colorectal cancer.
Sungjin ParkJungsuk AnSeung Yeon HaSeungyoon NamJung Ho KimPublished in: Journal of gastroenterology and hepatology (2022)
This study suggests that immunotherapy may be suitable for some obesity-associated CRC patients.
Keyphrases
- insulin resistance
- metabolic syndrome
- end stage renal disease
- weight loss
- type diabetes
- newly diagnosed
- weight gain
- chronic kidney disease
- high fat diet induced
- prognostic factors
- peritoneal dialysis
- adipose tissue
- patient reported outcomes
- risk assessment
- skeletal muscle
- body mass index
- human health
- patient reported